Literature DB >> 30496452

Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.

Lennart Well1, Johannes Salamon1, Michael G Kaul1, Said Farschtschi2, Jochen Herrmann1, Karin I Geier1, Christian Hagel3, Maximilian Bockhorn4, Peter Bannas1, Gerhard Adam1, Victor F Mautner2, Thorsten Derlin5.   

Abstract

BACKGROUND: We sought to determine the value of diffusion-weighted (DW) magnetic resonance imaging (MRI) for characterization of benign and malignant peripheral nerve sheath tumors (PNSTs) in patients with neurofibromatosis type 1 (NF1).
METHODS: Twenty-six patients with NF1 and suspicion of malignant transformation of PNSTs were prospectively enrolled and underwent DW MRI at 3T. For a set of benign (n = 55) and malignant (n = 12) PNSTs, functional MRI parameters were derived from both biexponential intravoxel incoherent motion (diffusion coefficient D and perfusion fraction f) and monoexponential data analysis (apparent diffusion coefficients [ADCs]). A panel of morphological MRI features was evaluated using T1- and T2-weighted imaging. Mann-Whitney U-test, Fisher's exact test, and receiver operating characteristic (ROC) analyses were applied to assess the diagnostic accuracy of quantitative and qualitative MRI. Cohen's kappa was used to determine interrater reliability.
RESULTS: Malignant PNSTs demonstrated significantly lower diffusivity (P < 0.0001) compared with benign PNSTs. The perfusion fraction f was significantly higher in malignant PNSTs (P < 0.001). In ROC analysis, functional MRI parameters showed high diagnostic accuracy for differentiation of PNSTs (eg, ADCmean, 92% sensitivity with 98% specificity, AUC 0.98; Dmean, 92% sensitivity with 98% specificity, AUC 0.98). By contrast, morphological imaging features had only limited sensitivity (18-94%) and specificity (18-82%) for identification of malignancy. Interrater reliability was higher for monoexponential data analysis.
CONCLUSION: DW imaging shows better diagnostic performance than morphological features and allows accurate differentiation of benign and malignant peripheral nerve sheath tumors in NF1.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  diffusion-weighted imaging; intravoxel incoherent motion analysis; morphological features; neurofibromatosis type 1; peripheral nerve sheath tumor

Mesh:

Year:  2019        PMID: 30496452      PMCID: PMC6422433          DOI: 10.1093/neuonc/noy199

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  37 in total

1.  MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.

Authors:  Junji Wasa; Yoshihiro Nishida; Satoshi Tsukushi; Yoji Shido; Hideshi Sugiura; Hiroatsu Nakashima; Naoki Ishiguro
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

2.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

3.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

4.  Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.

Authors:  Reinhard E Friedrich; Lan Kluwe; C Fünsterer; V F Mautner
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

5.  Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Authors:  Thorsten Derlin; Katharina Tornquist; Silvia Münster; Ivayla Apostolova; Christian Hagel; Reinhard E Friedrich; Ulrike Wedegärtner; Victor F Mautner
Journal:  Clin Nucl Med       Date:  2013-01       Impact factor: 7.794

6.  Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.

Authors:  M Trojani; G Contesso; J M Coindre; J Rouesse; N B Bui; A de Mascarel; J F Goussot; M David; F Bonichon; C Lagarde
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

7.  Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

Authors:  M Zöller; B Rembeck; H O Akesson; L Angervall
Journal:  Acta Derm Venereol       Date:  1995-03       Impact factor: 4.437

8.  Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient.

Authors:  Masayuki Maeda; Akihiko Matsumine; Hiroya Kato; Katsuyuki Kusuzaki; Stephan E Maier; Atsumasa Uchida; Kan Takeda
Journal:  J Magn Reson Imaging       Date:  2007-06       Impact factor: 4.813

9.  [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.

Authors:  R E Ferner; J F Golding; M Smith; E Calonje; W Jan; V Sanjayanathan; M O'Doherty
Journal:  Ann Oncol       Date:  2007-10-11       Impact factor: 32.976

10.  Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.

Authors:  Scott R Plotkin; Miriam A Bredella; Wenli Cai; Ara Kassarjian; Gordon J Harris; Sonia Esparza; Vanessa L Merker; Lance L Munn; Alona Muzikansky; Manor Askenazi; Rosa Nguyen; Ralph Wenzel; Victor F Mautner
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  11 in total

Review 1.  Spinal manifestations of Neurofibromatosis type 1.

Authors:  Ben Shofty; Ori Barzilai; Morsi Khashan; Zvi Lidar; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-20       Impact factor: 1.475

Review 2.  Soft-tissue sarcoma in adolescents and young adults.

Authors:  Toshiyuki Kunisada; Eiji Nakata; Tomohiro Fujiwara; Ako Hosono; Shota Takihira; Hiroya Kondo; Toshifumi Ozaki
Journal:  Int J Clin Oncol       Date:  2022-01-27       Impact factor: 3.402

3.  PET/MRI Improves Management of Children with Cancer.

Authors:  Lucia Baratto; K Elizabeth Hawk; Lisa States; Jing Qi; Sergios Gatidis; Louise Kiru; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2021-10       Impact factor: 10.057

Review 4.  Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.

Authors:  Jun Liu; Jing-Ning Huang; Ming-Han Wang; Zhen-Yang Ni; Wei-Hao Jiang; Manhon Chung; Cheng-Jiang Wei; Zhi-Chao Wang
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

Review 5.  Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease.

Authors:  Enrico Martin; Uta E Flucke; J Henk Coert; Max M van Noesel
Journal:  Childs Nerv Syst       Date:  2020-06-03       Impact factor: 1.475

6.  A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.

Authors:  Enrico Martin; Ritchie T J Geitenbeek; J Henk Coert; David F Hanff; Laura H Graven; Dirk J Grünhagen; Cornelis Verhoef; Walter Taal
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

Review 7.  Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 2: vascular lesions, fibrohistiocytic tumors, muscle tumors, peripheral nerve sheath tumors, tumors of uncertain differentiation, and undifferentiated small round cell sarcomas.

Authors:  Ezekiel Maloney; Khalid Al-Dasuqi; Lina Irshaid; Annie Wang; Kimia Kani; Andrew Haims; Jack Porrino
Journal:  Skeletal Radiol       Date:  2021-07-23       Impact factor: 2.199

8.  Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.

Authors:  Shivani Ahlawat; K Ina Ly; Laura M Fayad; Michael J Fisher; Andrés J Lessing; Dale J Berg; Johannes M Salamon; Victor-Felix Mautner; Dusica Babovic-Vuksanovic; Eva Dombi; Gordon Harris; Scott R Plotkin; Jaishri Blakeley
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

9.  Oncological Treatment Considerations Differ across Surgical Subspecialties Treating Malignant Peripheral Nerve Sheath Tumors: An International Survey.

Authors:  Enrico Martin; Willem-Bart M Slooff; Winan J van Houdt; Thijs van Dalen; Cornelis Verhoef; J Henk Coert
Journal:  Sarcoma       Date:  2020-02-27

Review 10.  Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.

Authors:  Samantha W E Knight; Tristan E Knight; Teresa Santiago; Andrew J Murphy; Abdelhafeez H Abdelhafeez
Journal:  Children (Basel)       Date:  2022-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.